vs
Oil-Dri Corp of America（ODC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Oil-Dri Corp of America的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$120.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -5.8%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.8%）
美国Oil-Dri公司是专业吸附剂及黏土基产品生产商，主营工业溢油清理吸附材料、猫砂等宠物护理产品、农业土壤改良剂及运动场场地调理材料，客户覆盖北美及全球多个商业领域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ODC vs PBYI — 直观对比
营收规模更大
ODC
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出33.5%
-5.8%
自由现金流更多
PBYI
多$13.1M
$1.3M
两年增速更快
PBYI
近两年复合增速
6.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $120.5M | $75.5M |
| 净利润 | $15.5M | — |
| 毛利率 | 29.5% | 69.3% |
| 营业利润率 | 14.1% | 22.7% |
| 净利率 | 12.8% | — |
| 营收同比 | -5.8% | 27.7% |
| 净利润同比 | -5.6% | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ODCPBYI
| Q4 25 | $120.5M | $75.5M | ||
| Q3 25 | $125.2M | $54.5M | ||
| Q2 25 | $115.5M | $52.4M | ||
| Q1 25 | $116.9M | $46.0M | ||
| Q4 24 | $127.9M | $59.1M | ||
| Q3 24 | $113.7M | $80.5M | ||
| Q2 24 | $106.8M | $47.1M | ||
| Q1 24 | $105.7M | $43.8M |
净利润ODCPBYI
| Q4 25 | $15.5M | — | ||
| Q3 25 | $13.1M | $8.8M | ||
| Q2 25 | $11.6M | $5.9M | ||
| Q1 25 | $12.9M | $3.0M | ||
| Q4 24 | $16.4M | — | ||
| Q3 24 | $8.5M | $20.3M | ||
| Q2 24 | $7.8M | $-4.5M | ||
| Q1 24 | $12.4M | $-4.8M |
毛利率ODCPBYI
| Q4 25 | 29.5% | 69.3% | ||
| Q3 25 | 27.8% | 77.7% | ||
| Q2 25 | 28.6% | 76.5% | ||
| Q1 25 | 29.5% | 77.1% | ||
| Q4 24 | 31.9% | 76.4% | ||
| Q3 24 | 29.0% | 63.9% | ||
| Q2 24 | 28.2% | 77.4% | ||
| Q1 24 | 29.3% | 75.5% |
营业利润率ODCPBYI
| Q4 25 | 14.1% | 22.7% | ||
| Q3 25 | 12.5% | 17.6% | ||
| Q2 25 | 12.0% | 12.7% | ||
| Q1 25 | 15.0% | 8.7% | ||
| Q4 24 | 16.6% | 22.6% | ||
| Q3 24 | 11.3% | 27.4% | ||
| Q2 24 | 9.8% | -4.6% | ||
| Q1 24 | 14.4% | -5.3% |
净利率ODCPBYI
| Q4 25 | 12.8% | — | ||
| Q3 25 | 10.4% | 16.2% | ||
| Q2 25 | 10.1% | 11.2% | ||
| Q1 25 | 11.1% | 6.5% | ||
| Q4 24 | 12.8% | — | ||
| Q3 24 | 7.5% | 25.2% | ||
| Q2 24 | 7.3% | -9.6% | ||
| Q1 24 | 11.7% | -11.0% |
每股收益（稀释后）ODCPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | — | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $266.5M | $130.3M |
| 总资产 | $380.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ODCPBYI
| Q4 25 | $42.4M | $97.5M | ||
| Q3 25 | $50.5M | $94.4M | ||
| Q2 25 | $36.5M | $96.0M | ||
| Q1 25 | $22.6M | $93.2M | ||
| Q4 24 | $12.5M | $101.0M | ||
| Q3 24 | $23.5M | $96.7M | ||
| Q2 24 | $46.8M | $96.8M | ||
| Q1 24 | $27.8M | $107.2M |
总债务ODCPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ODCPBYI
| Q4 25 | $266.5M | $130.3M | ||
| Q3 25 | $259.1M | $115.3M | ||
| Q2 25 | $246.9M | $104.7M | ||
| Q1 25 | $235.9M | $97.1M | ||
| Q4 24 | $224.0M | $92.1M | ||
| Q3 24 | $210.6M | $71.1M | ||
| Q2 24 | $202.9M | $48.5M | ||
| Q1 24 | $196.0M | $51.0M |
总资产ODCPBYI
| Q4 25 | $380.7M | $216.3M | ||
| Q3 25 | $391.7M | $202.9M | ||
| Q2 25 | $369.5M | $194.9M | ||
| Q1 25 | $353.7M | $196.2M | ||
| Q4 24 | $350.2M | $213.3M | ||
| Q3 24 | $354.6M | $220.7M | ||
| Q2 24 | $319.2M | $205.0M | ||
| Q1 24 | $296.2M | $214.1M |
负债/权益比ODCPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $1.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 1.1% | 19.1% |
| 资本支出强度资本支出/营收 | 7.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.67× | — |
| 过去12个月自由现金流最近4个季度 | $50.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ODCPBYI
| Q4 25 | $10.3M | $14.4M | ||
| Q3 25 | $25.2M | $9.7M | ||
| Q2 25 | $22.7M | $14.1M | ||
| Q1 25 | $21.4M | $3.6M | ||
| Q4 24 | $10.9M | $15.6M | ||
| Q3 24 | $23.4M | $11.0M | ||
| Q2 24 | $19.0M | $1.0M | ||
| Q1 24 | $9.4M | $11.2M |
自由现金流ODCPBYI
| Q4 25 | $1.3M | $14.4M | ||
| Q3 25 | $17.1M | $9.7M | ||
| Q2 25 | $16.0M | $14.1M | ||
| Q1 25 | $16.4M | $3.6M | ||
| Q4 24 | $-1.9M | $15.6M | ||
| Q3 24 | $15.1M | $11.0M | ||
| Q2 24 | $10.8M | $1.0M | ||
| Q1 24 | $1.9M | — |
自由现金流率ODCPBYI
| Q4 25 | 1.1% | 19.1% | ||
| Q3 25 | 13.7% | 17.7% | ||
| Q2 25 | 13.8% | 26.8% | ||
| Q1 25 | 14.0% | 7.7% | ||
| Q4 24 | -1.5% | 26.4% | ||
| Q3 24 | 13.3% | 13.7% | ||
| Q2 24 | 10.1% | 2.1% | ||
| Q1 24 | 1.8% | — |
资本支出强度ODCPBYI
| Q4 25 | 7.5% | 0.0% | ||
| Q3 25 | 6.5% | 0.0% | ||
| Q2 25 | 5.8% | 0.0% | ||
| Q1 25 | 4.3% | 0.1% | ||
| Q4 24 | 10.0% | 0.0% | ||
| Q3 24 | 7.3% | 0.0% | ||
| Q2 24 | 7.7% | 0.0% | ||
| Q1 24 | 7.1% | 0.0% |
现金转化率ODCPBYI
| Q4 25 | 0.67× | — | ||
| Q3 25 | 1.93× | 1.10× | ||
| Q2 25 | 1.95× | 2.41× | ||
| Q1 25 | 1.66× | 1.21× | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 2.74× | 0.54× | ||
| Q2 24 | 2.44× | — | ||
| Q1 24 | 0.76× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ODC
| Cat Litter | $64.6M | 54% |
| Fluids Purification | $26.7M | 22% |
| Agriculturaland Horticultural | $12.9M | 11% |
| Industrialand Sports | $11.6M | 10% |
| Animal Healthand Nutrition | $4.7M | 4% |
PBYI
暂无分部数据
